http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007509883-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007509883-A |
| titleOfInvention | Combinations comprising AMPA receptor antagonists for the treatment of schizophrenia |
| abstract | The present invention relates to a combination suitable for the treatment of psychiatric / neurological disorders, in particular schizophrenia. The combination comprises at least one AMPA receptor antagonist and (a) an antiepileptic agent selected from barbiturates and derivatives thereof, benzodiazepines, carboxamides, hydantoins, succinimides, valproic acid and other fatty acid derivatives and other antiepileptic agents; (b) at least one compound selected from the group consisting of conventional antipsychotics and (c) atypical antipsychotics. |
| priorityDate | 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.